Chitosan Derivatives Associated with Ceftazidime: Study of Controlled Release and Antibacterial Activity.

Luizângela da Silva Reis, Roosevelt D S Bezerra, Humberto M Barreto, Josy A Osajima, Edson C Silva-Filho

Abstract read

In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luizângela da Silva ReisLaboratory of Biology, Department of Biology, Federal University of Piaui (UFPI), Floriano, Piauí 64800-000, Brazil.

Roosevelt D S BezerraFederal Institute of Education, Science and Technology of Piauí (IFPI), Teresina-Central Campus, Teresina, Piauí 64000-040, Brazil.ORCID https://orcid.org/0000-0002-1820-076X

Humberto M BarretoMicrobiology Research Laboratory, Federal University of Piauí, Ministro Petrônio Portella University Campus, Teresina 64049-550, Piauí Brazil.ORCID https://orcid.org/0000-0001-5054-7555

Josy A OsajimaInterdisciplinary Advanced Materials Laboratory (LIMAV), Materials Science and Engineering Graduate Program, Federal University of Piaui (UFPI), Teresina, Piauí 64049-550, Brazil.ORCID https://orcid.org/0000-0001-7089-3244

Edson C Silva-FilhoInterdisciplinary Advanced Materials Laboratory (LIMAV), Materials Science and Engineering Graduate Program, Federal University of Piaui (UFPI), Teresina, Piauí 64049-550, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The search for new low-cost and nontoxic materials with the potential for controlled drug release and antibacterial activity has intensified recently. Due to their unique properties, chitosan derivatives have emerged as promising candidates for these applications. This study evaluated the ability of three chitosan derivatives to incorporate and control the release of the ceftazidime (CFZ) drug, as well as to investigate the antibacterial activity of these derivatives when combined with CFZ against

Identifiers

PMID41078762

DOI10.1021/acsomega.5c06901

PMCPMC12509009

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.